Inhibitor development according to concentrate in severe hemophilia: reporting on 1392 Previously Untreated Patients from Europe and Canada

CONCLUSION: While confirming expected rates of inhibitors in PUPs, inhibitor development was lower in pdFVIII than in SHL-rFVIII. Preliminary data suggest variation in inhibitor development among different SHL-rFVIII and EHL-rFVIII concentrates.PMID:38193044 | PMC:PMC10772871 | DOI:10.1016/j.rpth.2023.102265

https://pubmed.ncbi.nlm.nih.gov/38193044/?utm_source=no_user_agent&utm_medium=rs...

Source: Thrombosis and Haemostasis - January 9, 2024 Category: Hematology Authors: Kathelijn Fischer Riitta Lassila Flora Peyvandi Alexander Gatt Rob Hollingsworth Thierry Lambert Radek Kaczmarek Amanda Bettle Nasrin Samji Georges- Étienne Rivard Manuel Carcao Alfonso Iorio Mike Makris EUHASS and CHESS participants Source Type: research